S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 12:53 AM ET

POM

Pomdoctor Limited

Price Chart
Latest Quote

$1.13

-0.24 (-17.52%)
Current Price
Previous Close $1.37
Open $1.38
Day High $1.38
Day Low $1.02
Volume 138,277
Fetched: 2026-07-17T20:33:26
Stock Information
Note: Financial values converted from CNY to USD
Shares Outstanding 6.77M
Total Debt $67.14M
Cash Equivalents $1.41M
Revenue $59.02M
Net Income $-31.37M
Sector Healthcare
Industry Pharmaceutical Retailers
Market Cap $8.42M
EPS (TTM) $-5.97
Exchange NGM
🌐 Visit Website
Recent Price History
Date Close Volume
2026-07-17 $1.13 137,900
2026-07-16 $1.37 28,600
2026-07-15 $1.51 20,500
2026-07-14 $1.44 22,900
2026-07-13 $1.42 17,300
2026-07-10 $1.53 30,900
2026-07-09 $1.65 28,800
2026-07-08 $1.45 12,200
2026-07-07 $1.52 5,900
2026-07-06 $1.45 20,800
2026-07-02 $1.60 46,700
2026-07-01 $1.64 120,400
2026-06-30 $1.45 51,400
2026-06-29 $1.48 43,300
2026-06-26 $1.48 105,700
2026-06-25 $1.42 102,200
2026-06-24 $1.33 37,800
2026-06-23 $1.39 163,700
2026-06-22 $1.40 99,800
2026-06-18 $1.30 157,211
About Pomdoctor Limited

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $51,307,338 $43,519,132 $39,278,461 $28,094,669
Cost Of Revenue $51,307,338 $43,519,132 $39,278,461 $28,094,669
Total Revenue $59,023,685 $50,558,326 $44,993,430 $36,191,680
Operating Revenue $59,023,685 $50,558,326 $44,993,430 $36,191,680
Expenses
Interest Expense $1,901,723 $1,913,451 $2,044,000 $2,364,898
Total Expenses $76,199,349 $54,006,522 $47,992,515 $36,680,813
Other Income Expense $-246,878 $-153,139 $-410,302 $-72,990
Other Non Operating Income Expenses $64,320 $177,246 $-173,120 $-72,990
Net Non Operating Interest Income Expense $-1,901,723 $-1,913,451 $-2,044,000 $-2,364,898
Interest Expense Non Operating $1,901,723 $1,913,451 $2,044,000 $2,364,898
Operating Expense $24,892,011 $10,487,390 $8,714,054 $8,586,144
Other Operating Expenses $-22,522 $-27,968 $-47,461 $-41,349
Selling And Marketing Expense $14,200,341 $8,319,155 $6,446,562 $7,004,467
General And Administrative Expense $8,815,490 $1,753,130 $1,817,433 $1,093,486
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-19,324,095 $-5,518,606 $-5,453,543 $-2,926,743
Net Interest Income $-1,901,723 $-1,913,451 $-2,044,000 $-2,364,898
Normalized Income $-19,012,898 $-5,188,221 $-5,216,361 $-2,926,743
Net Income From Continuing And Discontinued Operation $-19,324,095 $-5,518,606 $-5,453,543 $-2,926,743
Total Operating Income As Reported $-17,509,383 $-3,806,550 $-3,283,729 $-530,482
Net Income Common Stockholders $-31,374,677 $-21,158,724 $-21,458,319 $-18,524,129
Net Income $-31,374,677 $-21,158,724 $-21,458,319 $-18,524,129
Net Income Including Noncontrolling Interests $-31,374,902 $-21,154,904 $-21,458,163 $-18,524,406
Net Income From Tax Loss Carryforward $-12,050,582 $-15,640,118 $-16,004,776 $-15,597,385
Net Income Continuous Operations $-19,324,319 $-5,514,786 $-5,453,387 $-2,927,021
Pretax Income $-19,324,264 $-5,514,786 $-5,453,387 $-2,927,021
Special Income Charges $-311,197 $-330,385 $-237,182 $0
Operating Income $-17,175,664 $-3,448,197 $-2,999,085 $-489,133
Gross Profit $7,716,348 $7,039,193 $5,714,969 $8,097,011
Per Share
Diluted EPS $-0.54 $-3.22 $-3.26 $-2.82
Basic EPS $-0.54 $-3.22 $-3.26 $-2.82
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-17,089,308 $-3,251,098 $-3,155,661 $-562,123
Total Unusual Items $-311,197 $-330,385 $-237,182 $0
Total Unusual Items Excluding Goodwill $-311,197 $-330,385 $-237,182 $0
Reconciled Depreciation $22,036 $19,852 $16,544 $0
EBITDA (Bullshit earnings) $-17,400,505 $-3,581,483 $-3,392,843 $-562,123
EBIT $-17,422,541 $-3,601,336 $-3,409,387 $-562,123
Diluted Average Shares $8,572,612 $971,183 $971,183 $971,183
Basic Average Shares $8,572,612 $971,183 $971,183 $971,183
Diluted NI Availto Com Stockholders $-31,374,677 $-21,158,724 $-21,458,319 $-18,524,129
Minority Interests $224 $-3,819 $-156 $277
Tax Provision $55 $0 $0 $0
Write Off $0 $0 $73,795 $0
Impairment Of Capital Assets $311,197 $330,385 $163,387 $0
Research And Development $1,898,702 $443,073 $497,520 $529,540
Selling General And Administration $23,015,831 $10,072,286 $8,263,995 $8,097,953
Other Gand A $8,815,490 $1,753,130 $1,817,433 $1,093,486
Fetched: 2026-07-17
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-67,001,887 $-334,059,777 $-312,900,281 $-291,441,962
Total Assets $15,874,464 $6,822,757 $9,786,363 $7,175,514
Total Non Current Assets $382,378 $1,288,491 $1,016,897 $129,529
Other Non Current Assets $198,396 $122,667 $81,101 $55,734
Non Current Deferred Assets $0 $1,097,731 $847,851 $0
Current Assets $15,492,086 $5,534,265 $8,769,465 $7,045,985
Prepaid Assets $9,192,680 $842,152 $1,111,322 $1,423,628
Inventory $1,222,071 $1,352,811 $1,873,577 $1,209,583
Receivables $3,663,362 $2,209,984 $4,780,198 $4,022,323
Receivables Adjustments Allowances $-335,120 $-395,222 $-292,081 $-213,529
Other Receivables $91,802 $79,424 $68,454 $62,959
Taxes Receivable $525,535 $395,776 $421,533 $0
Accounts Receivable $2,844,354 $1,298,630 $4,227,532 $4,172,894
Allowance For Doubtful Accounts Receivable $-97,756 $-119,009 $-124,962 $0
Gross Accounts Receivable $2,942,110 $1,417,639 $4,352,494 $4,172,894
Cash Cash Equivalents And Short Term Investments $1,413,972 $1,129,318 $991,371 $366,851
Cash And Cash Equivalents $1,413,972 $1,129,318 $991,371 $366,851
Restricted Cash - $0 $12,998 $23,599
Debt
Net Debt $65,311,791 $63,521,672 $59,640,409 $51,049,844
Total Debt $67,144,848 $65,102,776 $60,998,347 $53,315,829
Long Term Debt And Capital Lease Obligation $54,709,758 $54,130,779 $52,633,764 $48,759,580
Long Term Debt $54,518,701 $53,883,975 $52,454,261 $47,070,754
Current Debt And Capital Lease Obligation $12,435,090 $10,971,998 $8,364,583 $4,556,249
Current Debt $12,207,062 $10,767,014 $8,177,519 $4,345,941
Other Current Borrowings $4,384,761 $5,607,493 $4,930,526 $2,863,827
Liabilities
Total Liabilities Net Minority Interest $86,909,322 $315,985,565 $299,273,444 $287,302,818
Total Non Current Liabilities Net Minority Interest $54,709,758 $289,545,379 $273,888,196 $266,107,621
Current Liabilities $32,199,564 $26,440,186 $25,385,248 $21,195,197
Current Deferred Liabilities $234,836 $259,176 $183,518 $403,313
Payables And Accrued Expenses $19,529,638 $14,901,942 $16,837,147 $16,235,634
Interest Payable $6,616,001 $5,423,803 $5,614,697 $4,247,659
Payables $10,761,669 $8,044,597 $9,776,748 $10,528,037
Other Payable $3,880,947 $4,171,543 $3,400,485 $3,833,533
Total Tax Payable $97,260 $120,355 $31,556 $48,583
Accounts Payable $6,615,187 $3,740,887 $6,152,919 $6,397,642
Other Current Liabilities - $307,071 - -
Equity
Common Stock Equity $-67,001,887 $-334,059,777 $-312,900,281 $-291,441,962
Total Equity Gross Minority Interest $-71,034,858 $-309,162,809 $-289,487,082 $-280,127,304
Stockholders Equity $-67,001,887 $-334,059,777 $-312,900,281 $-291,441,962
Other Equity Interest $-323 $-237 $-237 -
Gains Losses Not Affecting Retained Earnings $-258,647 $-772 $0 -
Other Equity Adjustments $-258,647 $-772 - -
Retained Earnings $-365,434,093 $-334,059,416 $-312,900,692 $-291,442,374
Preferred Securities Outside Stock Equity $0 $235,414,601 $221,254,432 $217,348,041
Other
Ordinary Shares Number $3,421,587 $2,913,550 $2,913,550 $2,913,550
Share Issued $3,421,587 $2,913,550 $2,913,550 $2,913,550
Tangible Book Value $-67,001,887 $-334,059,777 $-312,900,281 $-291,441,962
Invested Capital $-276,124 $-269,408,787 $-252,268,501 $-240,025,267
Working Capital $-16,707,478 $-20,905,920 $-16,615,783 $-14,149,212
Capital Lease Obligations $419,085 $451,787 $366,567 $1,899,134
Total Capitalization $-12,483,186 $-280,175,801 $-260,446,020 $-244,371,208
Minority Interest $-4,032,971 $24,896,968 $23,413,199 $11,314,658
Additional Paid In Capital $298,688,754 $0 - -
Capital Stock $2,421 $649 $649 $411
Common Stock $2,421 $649 $649 $411
Long Term Capital Lease Obligation $191,057 $246,804 $179,503 $1,688,826
Current Deferred Revenue $234,836 $259,176 $183,518 $403,313
Current Capital Lease Obligation $228,028 $204,983 $187,064 $210,307
Line Of Credit $7,822,301 $5,159,521 $3,246,993 $1,482,114
Current Accrued Expenses $8,767,969 $6,857,345 $7,060,400 $5,707,597
Dueto Related Parties Current $168,276 $11,813 $191,789 $248,278
Net PPE $183,982 $68,093 $87,945 $0
Accumulated Depreciation $-1,606,359 $-1,596,728 $-1,577,822 $-1,581,101
Gross PPE $1,790,341 $1,664,821 $1,665,767 $1,581,101
Leases $702,374 $702,374 $702,374 $716,469
Machinery Furniture Equipment $1,087,967 $962,447 $963,393 $864,632
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-278,007 $-72,977 $-74,250 -
Finished Goods $1,500,078 $1,425,789 $1,947,827 $1,209,583
Duefrom Related Parties Current $536,793 $831,376 $354,760 -
Investments And Advances - - $0 $73,795
Fetched: 2026-07-17
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-22,062,934 $-2,386,341 $-6,775,526 $-3,249,547
Operating Activities
Operating Cash Flow $-21,914,199 $-2,380,766 $-6,759,012 $-3,249,547
Cash Flow From Continuing Operating Activities $-21,914,199 $-2,380,766 $-6,759,012 $-3,249,547
Operating Gains Losses - $-575 - -
Investing Activities
Capital Expenditure $-148,735 $-5,575 $-16,514 -
Investing Cash Flow $-237,289 $-4,926 $-16,514 $0
Cash Flow From Continuing Investing Activities $-237,289 $-4,926 $-16,514 $0
Net Other Investing Changes $-88,554 - - -
Financing Activities
Issuance Of Capital Stock $24,194,911 $0 $0 -
Financing Cash Flow $22,718,134 $2,511,413 $7,389,444 $3,319,603
Cash Flow From Continuing Financing Activities $22,718,134 $2,511,413 $7,389,444 $3,319,603
Net Other Financing Charges $-3,551,550 - $-336,053 -
Net Common Stock Issuance $24,194,911 $0 $0 -
Common Stock Issuance $24,194,911 $0 $0 -
Other
Repayment Of Debt $-11,316,102 $-10,071,862 $-12,428,612 $-1,909,170
Issuance Of Debt $13,390,875 $12,583,276 $20,154,109 $5,228,772
Interest Paid Supplemental Data $399,026 $405,106 $352,450 $477,577
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $1,413,972 $1,129,318 $1,004,369 $390,450
Beginning Cash Position $1,129,318 $1,004,369 $390,450 $320,394
Effect Of Exchange Rate Changes $-281,992 $-772 $0 -
Changes In Cash $566,645 $125,722 $613,919 $70,056
Net Issuance Payments Of Debt $2,074,773 $2,511,413 $7,725,497 $3,319,603
Net Short Term Debt Issuance $2,662,780 $1,912,528 $1,820,605 $1,265,380
Short Term Debt Payments $-5,602,293 $-4,596,217 $-2,311,932 $-225,019
Short Term Debt Issuance $8,265,073 $6,508,745 $4,132,537 $1,490,399
Net Long Term Debt Issuance $-588,007 $598,885 $5,904,893 $2,054,222
Long Term Debt Payments $-5,713,809 $-5,475,645 $-10,116,680 $-1,684,151
Long Term Debt Issuance $5,125,802 $6,074,531 $16,021,573 $3,738,373
Net PPE Purchase And Sale $-148,735 $-4,926 $-16,514 $0
Sale Of PPE $0 $649 $0 $0
Purchase Of PPE $-148,735 $-5,575 $-16,514 $0
Change In Working Capital $-5,589,535 $2,587,155 $-1,853,283 $-208,225
Change In Other Working Capital $-24,340 $75,658 $-219,795 $188,392
Change In Other Current Liabilities $-640,160 $148,256 $-294,341 $-370,082
Change In Other Current Assets $12,826 $-41,566 $-25,367 $0
Change In Payables And Accrued Expense $4,977,747 $-758,140 $89,714 $4,114,462
Change In Accrued Expense $718,426 $-12,160 $-14,235 $68,140
Change In Payable $4,259,321 $-745,979 $103,949 $4,046,322
Change In Account Payable $2,874,300 $-2,412,032 $-244,724 $1,910,045
Change In Tax Payable $-23,095 $88,724 $-17,028 $-4,763
Change In Income Tax Payable $-23,095 $88,724 $-17,028 $-4,763
Change In Prepaid Assets $36,893 $287,921 $-7,925 $-181,864
Change In Inventory $-147,267 $447,788 $-738,243 $-11,448
Change In Receivables $-9,805,234 $2,427,239 $-657,326 $-3,947,685
Changes In Account Receivables $-1,550,670 $2,934,855 $-187,960 $-3,851,710
Stock Based Compensation $2,423,981 $0 $0 -
Provisionand Write Offof Assets $242,440 $197,202 $293,932 $-114,301
Asset Impairment Charge $311,197 $330,385 $237,182 $0
Depreciation Amortization Depletion $22,036 $19,852 $16,544 $0
Depreciation And Amortization $22,036 $19,852 $16,544 $0
Depreciation $22,036 $19,852 $16,544 $0
Gain Loss On Sale Of PPE $0 $-575 $0 -
Net Income From Continuing Operations $-19,324,319 $-5,514,786 $-5,453,387 $-2,927,021
Net Investment Purchase And Sale - - - $0
Purchase Of Investment - - - $0
Amortization Cash Flow - - - $0
Amortization Of Intangibles - - - $0
Fetched: 2026-07-17